When most of the companies were discussing how they got impacted by the deadly virus and the uncertainties they faced in the
Categories
Health Care
Veru Inc is venturing into COVID-19 vaccine hunt
Veru Inc (NASDAQ: VERU) is the latest company to jump into the bandwagon of firms around the world vying for a drug
Teleflex Inc. (NYSE: TFX) Q1 2020 Earnings Call Transcript
Teleflex Inc. (TFX) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Jake Elguicze -- Treasurer and Vice President of Investor Relations Liam
Hologic Inc (NASDAQ: HOLX) Q2 2020 Earnings Call Transcript
Hologic Inc (HOLX) Q2 2020 earnings call dated Apr. 29, 2020 Corporate Participants: Michael Watts -- Vice President of Investor Relations and Corporate Communications
Laboratory Corp Of America Holdings (NYSE: LH) Q1 2020 Earnings Call Transcript
Laboratory Corp Of America Holdings (LH) Q1 2020 earnings call dated Apr. 29, 2020 Corporate Participants: Clarissa Willett -- Vice President, Investor Relations Adam
Key highlights from SmileDirectClub (SDC) Q1 2020 earnings results
SmileDirectClub, Inc. (NASDAQ: SDC) reported its financial results for the quarter ended March 31, 2020, on Wednesday after the market closes. The
Veru Inc. (NASDAQ: VERU) Q2 2020 Earnings Call Transcript
Veru Inc. (VERU) Q2 2020 earnings call dated May 13, 2020 Corporate Participants: Sam Fisch -- Director of Investor Relations Mitchell Steiner -- Chairman, President and
HCA Holdings Inc. (NYSE: HCA) Q1 2020 Earnings Call Transcript
HCA Holdings Inc. (HCA) Q1 2020 earnings call dated Apr. 21, 2020 Corporate Participants: Mark Kimbrough -- Vice President Investor Relations Samuel N. Hazen -- Chief
Veru (VERU) posts narrower-than-expected loss in Q2
Veru Inc. (NASDAQ: VERU) reported its financial results for the quarter ended March 31, 2020, on Wednesday before the market opens. The
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Q1 2020 Earnings Call Transcript
Catalyst Pharmaceuticals Inc (CPRX) Q1 2020 earnings call dated May 12, 2020 Corporate Participants: Alicia Grande -- Vice President, Chief Financial Officer and Treasurer
Fueled by funding, Novavax (NVAX) gains ground in race for Covid-19 vaccine
For Novavax Inc. (NASDAQ: NVAX), the new fiscal year is of great significance due to the progress it has achieved in developing
INOVIO Pharmaceuticals expects results from initial trials for COVID-19 vaccine next month
INOVIO Pharmaceuticals (NASDAQ: INO), which is among the frontrunners in developing a vaccine for the coronavirus disease, said during its post-earnings conference
Inovio Pharmaceuticals Inc (NASDAQ: INO) Q1 2020 Earnings Call Transcript
Inovio Pharmaceuticals Inc (INO) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Ben Matone -- Investor Relations J. Joseph Kim, Ph.D. -- President, Chief
Key highlights from Palatin Technologies (PTN) Q3 2020 earnings results
Palatin Technologies, Inc. (NYSE: PTN) reported a narrower loss in the third quarter of fiscal 2020 helped by lower operating expenses as
Cara Therapeutics Inc. (NASDAQ: CARA) Q1 2020 Earnings Call Transcript
Cara Therapeutics Inc. (CARA) Q1 2020 earnings call dated May 11, 2020 Corporate Participants: Jack Hildick-Smith -- Investor Relations Derek Chalmers -- Chief Executive Officer, President,
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) Q1 2020 Earnings Call Transcript
Intercept Pharmaceuticals Inc (ICPT) Q1 2020 earnings call dated May 11, 2020 Corporate Participants: Lisa DeFrancesco -- Vice President, Investor Relations Mark Pruzanski -- President, Chief
Mylan N.V. (NASDAQ: MYL) Q1 2020 Earnings Call Transcript
Mylan N.V. (MYL) Q1 2020 earnings call dated May 11, 2020 Corporate Participants: Melissa Trombetta -- Head of Global Investor Relations Robert J. Coury -- Executive
Novavax Inc. (NASDAQ: NVAX) Q1 2020 Earnings Call Transcript
Novavax Inc. (NVAX) Q1 2020 earnings call dated May 11, 2020 Corporate Participants: Erika Trahan -- Investor Relations Stanley C. Erck -- President and Chief Executive
NVAX Earnings: Key highlights from Novavax Q1 2020 results
Novavax, Inc. (NASDAQ: NVAX) today announced its first quarter financial results for the period ended March 31, 2020. NVAX reported net loss
AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) Q1 2020 Earnings Call Transcript
AMAG Pharmaceuticals Inc. (AMAG) Q1 2020 earnings call dated May 11, 2020 Corporate Participants: Linda Lennox -- Vice President of Investor Relations and Corporate
Eagle Pharmaceuticals Inc (NASDAQ: EGRX) Q1 2020 Earnings Call Transcript
Eagle Pharmaceuticals Inc (EGRX) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Lisa Wilson -- Investor Relations Scott Tarriff -- Founder, Chief Executive Officer